Diphenylhydantoin Metabolism in Uremia
Authors:
- Joseph M. LetteriJLJoseph M. Letteri
- Harlan MellkHMHarlan Mellk
- Sydney LouisSLSydney Louis
- Henn KuttHKHenn Kutt
- Peter DurantePDPeter Durante
- Anthony GlazkoAGAnthony Glazko
- 16 September 1971
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 285 (12) , 648-652
Abstract
Diphenylhydantoin was administered orally or intravenously to 20 uremic and 20 nonuremic patients. In the former this drug and 5-phenyl-5-parahydroxyl-phenylhydantoin, its major metabolite, were measured in blood and urine. In the nonuremic patients, only diphenylhydantoin levels in plasma were measured. Regardless of the route of administration, diphenylhydantoin concentrations were uniformly lower in uremic than in nonuremic patients. In uremic patients, plasma concentrations of 5-phenyl-5-parahydroxyl-phenylhydantoin were higher than reported values in nonuremic subjects. After a single intravenous injection of 250 mg of diphenylhydantoin, its rate of elimination from plasma (half-life) was 8.1 hours in five uremic patients and 13.0 hours in three nonuremic subjects. These observations suggest an altered metabolic disposition of the drug in uremia.Keywords
This publication has 15 references indexed in Scilit:
- Colorimetric Assay of 5,5-Diphenylhydantoin (Dilantin) and 5- (p-Hydroxyphenyl)-5-phenylhydantoinExperimental Biology and Medicine, 1971
- A new metabolite of 5,5-diphenylhydantoin (Dilantin++Dilantin is the Parke-Davis trade name for 5,5-diphenylhydatoin (phenytoin).)Biochemical and Biophysical Research Communications, 1970
- Metabolic disposition of diphenylhydantoin in normal human subiects following intravenous administrationClinical Pharmacology & Therapeutics, 1969
- The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomesNeurology, 1969
- Intravenous Diphenylhydantoin in Experimental SeizuresArchives of Neurology, 1968
- Neurologic disorders in renal failureThe American Journal of Medicine, 1968
- Intramuscular administration of phenytoinNeurology, 1966
- Neurological complications of dialysis, transplantation, and other forms of treatment in chronic uremiaNeurology, 1965
- Insufficient parahydroxylation as a cause of diphenylhydantoin toxicityNeurology, 1964
- Studies on the metabolism of diphenylhydantoin (Dilantin)Neurology, 1961